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Abstract 
Background: Despite the fact that melatonin treatment shows some promise in gastric cancer, the molecular 
mechanisms of gastric cancer cells in response to melatonin remains to be determined.
Methods: The SGC-7901 gastric cancer cells were treated with different concentrations of melatonin for 24 and 48 h. 
Cell viability was determined by MTT assay, Hoechst 33258 staining and FACS analysis were used to detect apoptotic 
cells. The contents and activation of apoptosis-related proteins HSP27, Akt and P38 were evaluated by immunoblot-
ting analysis. Then we treated SGC-7901 cells with HSP27-specific siRNA, PI3K inhibitor LY294002 or P38 inhibitor 
SB203580 to investigate the role of HSP27, Akt and P38 in the anti-apoptotic response of SGC-7901 cells to melatonin.
Results: Melatonin suppressed cell viability and stimulated apoptosis of gastric cancer SGC-7901 cells dose-
dependently. Mechanistically, the observed apoptosis was accompanied by the melatonin-induced phosphorylation 
of HSP27. HSP27-specific siRNA transfection effectively reduced HSP27 phosphorylation and augmented melatonin-
induced apoptosis, indicating that HSP27 is resistant to melatonin-induced apoptosis. Moreover, melatonin increased 
PI3K/Akt activation, LY294002 abrogated HSP27 activation and promoted cell apoptosis induced by melatonin. Fur-
thermore, melatonin increased P38 activity, and P38 inhibitor SB203580 inhibited melatonin-induced PI3K/Akt, HSP27 
activation and accelerated cell apoptosis.
Conclusion: In contrast to the well-established anti-cancer properties of melatonin, our study revealed clearly a dis-
tinguishable anti-apoptotic pathway induced by melatonin, that is, HSP27 plays a crucial role in apoptotic resistance 
in melatonin-treated gastric cancer cells, and its activation is most likely via the activation of P38/PI3K/Akt signaling.
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Background
Gastric cancer has become the fourth most common 
malignancy and the second in mortality of total can-
cer worldwide [1]. It is estimated that in 2012 there 
were 951,600 new cases and 723,100 deaths from gas-
tric cancer in the world [2]. Despite the development 
of therapeutic intervention for gastric cancer in clinical 
trials, drug resistance is still the major reason why failure 
occurs in gastric cancer treatment. As reviewed recently, 
melatonin, an indolamine derived from the l-tryptophan, 
has been shown to exert important protective effects in 
the gastrointestinal tract [3]. Although further study in 
additional settings and populations is required, mela-
tonin is of great interest among the compounds tested as 
a potential therapy in gastric cancer.
Melatonin is an endogenous hormone that is required 
for the daily onset of darkness. Besides its use in the 
treatment of some sleep disorders, melatonin has been 
characterized as possessing a pro-apoptotic role in the 
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treatment of cancer, and there seems to be some prom-
ise in several types of cancers such as breast, prostate 
as well as colorectal cancer [4–6]. There is at least 400 
times more melatonin produced in the gastrointestinal 
tract than in the pineal gland [7], and melatonin has been 
demonstrated to suppress gastrointestinal carcinogenesis 
under some circumstances such as chronic inflammation 
[8, 9]. The safety of melatonin heralds it as a great pros-
pect for gastrointestinal cancer therapy [3], however, the 
molecular mechanism related to its effect on gastric can-
cer remains unelucidated.
HSP27, a member of the small heat shock protein 
(HSP) family, is believed to have tumorigenic and pro-
metastatic functions, characterized by its dynamic phos-
phorylation leading to heterogeneous oligomerization 
under different conditions such as oxidative stress, heat 
shock as well as chemical stress [10]. In fact, epidemio-
logic surveys have demonstrated that HSP27 is upregu-
lated in many cancers including ovarian cancer, colorectal 
cancer and gastric cancer, where it has been identified as 
a tumor prognostic marker [11–13]. HSP27 is also closely 
correlated with increased resistance to apoptosis in 
stressed cancer cells. For example, HSP27 accumulation 
reduces the chemosensitivity induced by vincristine and 
adriamycin agents in gastric cancer cells [14]. In contrast, 
a combination of traditional chemotherapeutic agents 
(cisplatin, gemcitabine) and HSP27 inhibitor (quecertin) 
exerts a surprising greater chemotherapeutic effect in 
lung stem like cells [15]. Thus, it is worthwhile to explore 
whether HSP27 is involved in melatonin-induced apop-
tosis of gastric cancer cells.
Recent studies from our laboratory showed that HSP27 
phosphorylation could be induced by P38 activation and 
phospho HSP27 acts as a regulator of cell cytoskeleton 
reorgnization and cell adhesive ability [16]. In addition, 
HSP27 has been found to direct chaperoning interac-
tion with Akt, and protest adenocarcinoma cells from 
UV-induced apoptosis [17]. Based on above information, 
we focused this study on HSP27 regulation of apoptosis 
induced by melatonin, and in an attempt to gain further 
mechanistic insights into the molecular pathways leading 
to melatonin-induced alteration of HSP27 phosphoryla-
tion in SGC-7901 gastric cancer cells.
Methods
Cell culture
Human gastric cancer cell line SGC-7901 was obtained 
from the Cell Biology Institute of Chinese Academy of 
Sciences (Shanghai, China). SGC-7901 cells were cul-
tured in Dulbecco’s modified Eagle’s medium (DMEM, 
high glucose) (Hyclone, Thermo Scientific, Waltham, 
MA, USA) supplemented with 10  % (v/v) fetal bovine 
serum (FBS) (Hyclone) and antibiotics (100  U/mL 
streptomycin and 100  μg/mL penicillin) (Invitrogen, 
USA) in a humidified incubator at 37  °C with 5 % CO2. 
Cells were grown on coverslips for fluorescence staining 
and on plastic dishes for protein extraction.
Treatment and transfection
Melatonin (Sigma, St Louis, MO, USA) was dissolved 
in ethanol and cells were treated with melatonin for the 
indicated times and doses. In experiments to determine 
the effects of inhibitors, LY294002 (Sigma) and SB203580 
(Beyotime, Nantong, China) on cell growth inhibition 
and apoptosis, cells were treated with these kinase inhibi-
tors for 30 min prior to melatonin treatment.
The sequences of small interfering RNA (siRNA) for 
HSP27 was 5′-UGAGAGACUGCCGCCAAGUAA-3′, 
the sequence of control siRNA was 5′-UUCUCCGA 
ACGUGUCACGUTT-3′ (GenePharma Co., Shanghai, 
China). Cells were transfected with control siRNA or 
HSP27 siRNA with Lipofectamine 2000, according to the 
manufacturer’s instruction.
Immunoblotting analysis
Subconfluent cells were washed with PBS, and lysed with 
RIPA lysis buffer (150  mmol/L NaCl, 50  mmol/L Tris–
HCl (pH 7.4), 1 % Triton X-100, 1 % sodium deoxycho-
late, 0.1 % SDS) with 1 mM sodium orthovanadate, 1 mM 
PMSF, and 1  % cocktail of protease inhibitors (Sigma). 
The lysates were clarified by centrifugation at 12,000g for 
20 min at 4 °C and separated by SDS-PAGE followed by 
transfer onto nitrocellulose membranes. The following 
antibodies were used: rabbit anti-P38 antibody, rabbit 
anti-P-P38 antibody, rabbit anti-P-Akt antibody, mouse 
anti-HSP27 antibody and rabbit anti-P-HSP27 antibody 
(Cell Signaling, Danvers, MA, USA), rabbit anti-Akt anti-
body (Bioworld, Louis Park, USA), rabbit anti-GAPDH 
antibody (Santa Cruz, CA, USA). Protein bands were 
detected by incubating with horseradish peroxidase-con-
jugated secondary antibodies (Santa Cruz) and visualized 
with ECL reagent (Millipore, Billerica, MA, USA). Digi-
tal images of immunoblots were obtained with a Chemi-
doc XRS and analyzed using the image analysis program 
Quantity One (Bio-Rad, Hercules, CA, USA).
Hoechst staining
Hoechst 33258 dyes (Beyotime) are cell permeable 
nucleic acid stains, which are useful for the recognition 
of DNA damage and cell apoptosis by monitoring the 
emission spectral shifts of the dyes. Cells were stained 
with Hoechst 33258 (5  μg/mL) in PBS for 30  min 
at room temperature, and then washed to remove 
unbound dye. Observation and photography was per-
formed in a fluorescence microscope (Olympus BX 51, 
Tokyo, Japan).
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Flow cytometry analysis
Cells were trypsinized and resuspended in 1× binding 
buffer, double-stained with Annexin V-FITC and propid-
ium iodide (Beyotime) at room temperature for 15 min in 
darkness. Subsequently, the stained cells were analyzed 
by flow cytometry for apoptotic analysis according to the 
manufacturer’s protocol.
Cell viability assay
Cell viability was determined by 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as 
described previously [18]. In brief, SGC-7901 cells were 
seeded at a density of 5 × 103 cells per well into 96-well 
plate and treated with melatonin for the indicated times 
and doses. After culture, cells were washed, MTT was 
added and the plate was incubated in the dark for 4  h, 
followed by measurement at 490 nm using a microplate 
absorbance reader (Bio-Tek, Elx800, USA). The per-
cent cell viability was calculated as the absorbance of 
melatonin treated sample/control sample absorbance 
×100 %.
Statistical analysis
Data were analyzed by Image J and statistical analyses 
were carried out using the SPSS software version 15.0 
(SPSS Inc., Chicago, IL, USA). Student’s t test was used 
to analyze differences between two groups. Statistical sig-
nificance was considered when P < 0.05.
Results
Melatonin promotes gastric cancer cell apoptosis in vitro
To assess the apoptosis effects of melatonin on gastric 
cancer cells, a widely used human gastric cancer cell line, 
SGC-7901, was employed. Clear evidence for apoptosis 
was obtained by monitored by fluorescence microscopy 
after staining with Hoechst 33258. As shown in Fig. 1a, 
b, in the control group, SGC-7901 cells exhibited regu-
lar shaped nuclei. In comparison, numbers of shrunken 
cells with condensed or fragmented nuclei, characteristic 
of apoptotic cells, were significantly increased in 1  mM 
melatonin treated cultures. We also treated cells with 
different doses of melatonin and cell viability was meas-
ured by MTT assay. As shown in Fig. 1c, the cell viabil-
ity decreased gradually in a dose-dependent manner. We 
also assessed cell apoptosis in response to 1  mM mela-
tonin treatment at 24 and 48  h, and SGC-7901 showed 
enhanced cell apoptosis in a time-dependent man-
ner (Fig.  1d). These results showed that melatonin sup-
pressed cell viability of SGC-7901 in  vitro. The marked 
decrease of cell viability by 1  mM melatonin treatment 
most likely reflected the induction of cell apoptosis by 
melatonin. Thus, 1  mM melatonin was used for further 
apoptosis studies.
Knockdown of HSP27 aggravates melatonin‑induced cell 
apoptosis
To explore the mechanism whereby melatonin stimulates 
gastric cancer cell apoptosis, we first examined endoge-
nous HSP27 activation after melatonin treatment. Mela-
tonin treatment resulted in a time-dependent increase in 
HSP27 activity, as determined by immunoblotting analy-
sis with an antibody against the phosphorylated form of 
HSP27. In contrast, the levels of total HSP27 were con-
stant at all these time points (Fig.  2a). We also treated 
cells with different doses of melatonin (0.01–1 mM) for 
24  h, and found that melatonin dose-dependently acti-
vated HSP27 in SGC-7901 cells (Fig.  2b). To determine 
the involvement of HSP27 in melatonin stimulated apop-
tosis of gastric cancer cells, specific siRNA for HSP27 
were applied to SGC-7901 cells. As shown in Fig.  2c, 
HSP27 siRNA greatly knocked down total and phospho-
rylated HSP27 expression. Treatment of cells with 1 mM 
melatonin increased the apoptosis of SGC-7901 cells 
when compared with control cells. As expected, HSP27 
knockdown not only resulted in a significant increase of 
melatonin-stimulated cell apoptosis, but also induced 
cell apoptosis in the absence of melatonin treatment in 
SGC-7901 cells (Fig. 2d, e). These results indicate that the 
knockdown of HSP27 may aggravate both basal and mel-
atonin-stimulated gastric cancer cell apoptosis.
PI3K/Akt mediates HSP27‑induced resistance to apoptosis 
induced by melatonin
To determine whether PI3K/Akt is the upstream media-
tor of HSP27 activation by melatonin in our system, 
immunoblotting analysis of P-Akt (Ser473), a well 
accepted downstream target of PI3K, was used to deter-
mine the PI3K activity [19, 20]. The results revealed 
a dose-dependent increase in PI3K activity following 
melatonin treatment. Immunoblotting analysis showed 
that the amount of phosphorylated Akt was increased 
significantly after melatonin stimulation with maxi-
mal activation at 1 mM (Fig. 3a). To determine whether 
melatonin-stimulated HSP27 activity is PI3K/Akt-
dependent, we blocked PI3K/Akt activity by treating 
the cells with LY294002, a PI3K inhibitor (Fig.  3b), and 
examined HSP27 activity after stimulation with mela-
tonin. The results showed that pretreatment with 10 μM 
LY294002 largely inhibited melatonin-induced Akt and 
HSP27 phosphorylation in comparison with control cells 
(Fig.  3c). The effect of PI3K inhibitor on cell apoptosis 
was also investigated using Hoechst 33258 assay. Pre-
treatment with 10  μM LY294002 resulted in a remark-
able enhancer of both basal and melatonin-promoted cell 
apoptosis (Fig.  3d). These results suggest that PI3K/Akt 
acts upstream of HSP27 in resisting melatonin-stimu-
lated gastric cancer cell apoptosis.
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P38 activation is required for melatonin‑induced PI3K/Akt/
HSP27 activation
We also examined the effect of melatonin on P38 activa-
tion in cultured gastric cancer cells. Melatonin treatment 
resulted in a dose-dependent increase in P38 activity, as 
determined by immunoblotting with an antibody against 
the phosphorylated form of P38 (Fig.  4a). To investigate 
whether P38 activation leads to melatonin-induced acti-
vation of the PI3K/Akt/HSP27 signaling pathway and cell 
apoptosis in cultured gastric cancer cells, SB203580, a 
known inhibitor of P38, was used and its effect on mela-
tonin-induced PI3K/Akt/HSP27 activation was examined. 
Pretreatment with 20 μM SB203580 remarkably abolished 
melatonin-induced PI3K/Akt (Fig. 4b) and HSP27 activa-
tion (Fig.  4c). These results indicate that melatonin can 
stimulate P38 activation in gastric cancer cells, and which 
may be an important mechanism for the stimulation of 
PI3K/Akt/HSP27 signaling pathway by melatonin.
Furthermore, by FACS analysis, we noticed that 
melatonin stimulated cell apoptosis was upregulated 
Fig. 1 Melatonin promotes apoptosis of SGC-7901 gastric cancer cells. SGC-7901 cells were incubated with melatonin for the indicated doses and 
periods. a The morphological figures of apoptosis were monitored by fluorescence microscopy after staining with Hoechst 33258. Images are rep-
resentative of at least three independent determinations. Scale bar 50 μm. b Melatonin-induced apoptosis of SGC-7901 gastric cancer cells. Values 
were presented as mean ± SD of three independent experiments. c Cell proliferation was measured by MTT assay. d Apoptosis was evaluated for 
up to 48 h by Hoechst 33258 staining. Images are representative of at least three independent determinations. Scale bar 50 μm. **P < 0.01
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Fig. 2 HSP27 phosphorylation is required for resistance of apoptosis by melatonin. a, b SGC-7901 cells were treated with melatonin for the 
indicated periods (a) and doses (b), and HSP27 phosphorylation was determined by immunoblotting assay. GAPDH was used as a loading control. 
*P < 0.05, **P < 0.01, referring to the difference between cells treated with and those without melatonin. c The expression of total and phosphoryla-
tion level of HSP27 after treatment with HSP27 siRNA. Total protein extracts from SGC-7901 cells transfected with HSP27 siRNA or control siRNA were 
analyzed by immunoblotting for P-HSP27 and HSP27. GAPDH was used as a loading control. d, e Cell apoptosis was determined by Hoechst 33258 
staining in the SGC-7901 cells transfected with control siRNA or HSP27 siRNA. d Images are representative of at least three independent determina-
tions. Scale bar 50 μm. e HSP27 siRNA treatment enhanced melatonin-induced apoptosis of SGC-7901 gastric cancer cells. Values were presented as 
mean ± SD of three independent experiments. **P < 0.01
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significantly by the pretreatment with LY294002 and 
SB203580, HSP27 knockdown also resulted in a sig-
nificant increase of melatonin-stimulated cell apoptosis 
(Fig. 5a). In the meantime, we noted that HSP27 silenc-
ing not only has no effect on melatonin stimulated P-Akt 
(Fig.  5c) and P-P38 (Fig.  5d) level, but also induced 
P-P38 and P-Akt expression in the absence of melatonin 
treatment. These results indicate that the activation of 
HSP27 is not essential for both basal and melatonin-
stimulated gastric cancer cell P38 and PI3K/Akt activa-
tion. Together, all the data above suggest a model that 
melatonin induces P38 activation, which stimulated acti-
vation of PI3K/Akt/HSP27 signaling for anti-apoptosis 
initiation (Fig. 5e).
Fig. 3 HSP27 enhanced cell resistance to melatonin-induced cell apoptosis is mediated through PI3K/Akt. a, b Effect of melatonin stimulation on 
phosphorylation of Akt. SGC-7901 cells were treated with melatonin under different concentrations of melatonin for 24 h. Melatonin-stimulated 
phosphorylation of Akt at Ser473 was determined by immunoblotting assay. GAPDH was used as a loading control. *P < 0.05, **P < 0.01, referring 
to the difference between cells treated with and those without melatonin. b, c After treatment with 10 μM PI3K inhibitor LY294002 for 30 min, SGC-
7901 cells were stimulated with 1 mM melatonin for 24 h and then cells were analyzed by P-Akt (b) and P-HSP27 (c) expression, and d the effect of 
LY294002 on the melatonin-stimulated apoptosis in SGC-7901 cells was determined. *P < 0.05, **P < 0.01
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Discussion
Besides its role in preventing angiogenic tumor cells 
dormancy [19], HSP27 is also essential in maintain-
ing normal homeostasis and morphology of malignant 
cells in response to stress conditions. Previous studies 
have shown that the susceptibility of gastric ulceration 
induced by NSAID was reduced in the transgenic mice 
which were overexpressed HSP27 [20]. Although HSP27 
phosphorylation contributes to arachidonic acid-induced 
apoptosis in brain endothelial cells [21], here, we reported 
that, in SGC-7901 gastric cancer cells, melatonin stimu-
lated HSP27 phosphorylation dose-dependently. Impor-
tantly, depletion of HSP27 resulted in an increase in the 
number of melatonin-induced apoptosis cells, indicating 
that HSP27 is actively involved in maintaining homeosta-
sis of SGC-7901 cells by inhibiting cell apoptosis. This is 
consistent with the observation that melatonin stimulates 
accumulation of nuclear phosphoHSP27 in human pan-
creatic carcinoma cells [22]. The reasons for these diver-
gent cellular outcomes are presently unclear, but HSP27 
interaction with distinct substrates, or binding partners 
after different stimulator treatment, might be able to 
explain the opposing responses on cell apoptosis. Actu-
ally, HSP27 could regulate apoptosis through an ability 
to interact with multiple points of the apoptotic signal-
ing pathway. For example, the phosphoHSP27 directly 
interacts with Daxx, preventing the interaction of Daxx 
with both Ask1 and Fas that mediates cell apoptosis [23]. 
Collectively, these findings attest to phosphoHSP27 being 
a potentially resistant molecule in apoptosis induced by 
melatonin.
We next examined the potential activators for HSP27 
in our system. Akt is a Ser/Thr kinase and downstream 
mediator of the PI3K pathway regulating cell survival, 
differentiation, and growth factor responsiveness. The 
frequent aberrant activation of the PI3K/Akt pathway in 
human cancer has made it an attractive therapeutic tar-
get [24]. In granular keratinocytes, Akt activation not 
only induced HSP27 phosphorylation, but also changes 
the equilibrium between cytoplasmic and nuclear phos-
phorylated HSP27, leading to its greater concentration 
in the cytoplasm [25]. In fact, it is reported that activa-
tion of Akt induced by phosphorylated HSP27 confers 
the apoptosis–resistance in t-AUCB-treated glioblas-
toma cells in vitro [26]. Our results show that melatonin 
induces a dose-dependent increase in PI3K/Akt activity. 
Blocking PI3K activity by LY294002 significantly prevents 
melatonin-induced HSP27 activation and aggravates cell 
apoptosis. Therefore, it may be reasonable to think that 
activation of PI3K/Akt signaling upon treatment with 
melatonin increased HSP27 phosphorylation, which was 
resistant to melatonin chemotherapy.
Several reports have demonstrated that HSP27 can 
form multicomponent complexes with Akt, and P38, 
and this complex has been shown to be involved in con-
trolling HSP27 phosphorylation and stress-induced 
apoptosis [17, 27, 28]. As reported previously, activa-
tion of P38 was accompanied by Akt suppression in the 
apoptotic process in some types of cancer cells [29, 30]. 
Conversely, there also has a good evidence suggesting 
a link from MEKK4 and P38, via HSP27, to Akt activa-
tion, which is essential for the regulation of cell fate in 
Fig. 4 P38 is required for the activation of PI3K/Akt and HSP27 by melatonin. a SGC-7901 cells were treated with melatonin for the indicated doses 
for 24 h, and HSP27 phosphorylation was determined by immunoblotting assay. *P < 0.05, **P < 0.01, referring to the difference between cells 
treated with and those without melatonin. b, c After treatment with 20 μM P38 inhibitor SB203580 for 30 min, SGC-7901 cells were stimulated with 
1 mM melatonin for 24 h, then the cells were analyzed by P-Akt (b) and P-HSP27 (c) expression. *P < 0.05
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Fig. 5 Effects of SB203580, LY294002 and HSP27 silencing on melatonin-induced cell apoptosis. a Effects of SB203580, LY294002 and siHSP27 on 
melatonin stimulated cell apoptosis and necrosis were measured with FACS assay. *P < 0.05, **P < 0.01. b, c After incubation with melatonin for 
24 h, total protein extracts from SGC-7901 cells transfected with HSP27 siRNA or control siRNA were analyzed by immunoblotting for P-Akt (b) and 
P-P38 (c). *P < 0.05
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response to apoptotic stress in human prostate cancer 
cells [31]. However, in gastric cancer cells, whether P38 
might affect the PI3K/Akt and HSP27 activation induced 
by melatonin is unknown. Here, our results clearly reveal 
that melatonin triggers a rapid stimulation of P38 activity. 
The selective P38 inhibitor SB203580 effectively blocks 
melatonin-stimulated PI3K/Akt and HSP27 activation. 
Consequently, we conclude that P38 is an upstream com-
ponent of PI3K/Akt/HSP27 signaling pathway in mela-
tonin-stimulated apoptosis in SGC-7901 gastric cancer 
cells.
Then another important question arises about the rela-
tionship between the activation of P38 and anti-apoptosis 
of PI3K/Akt/HSP27 after melatonin treatment. Accumu-
lating evidence suggests that P38 could be strongly acti-
vated by environmental and genotoxic stresses [32]. 
Notably, P38 plays a dual role in stress-induced apoptosis. 
On the one hand, many chemotherapeutic agents includ-
ing melatonin require P38 activity for the induction of 
apoptosis [33], on the other hand, the P38/HSP27 axis 
plays an important role in mediated drug resistance in 
cancer treatment [34]. Accordingly, we found that when 
P38 activity was blocked by its inhibitor, melatonin-stim-
ulated cell apoptosis was dramatically increased, indicat-
ing that P38 activation is resistant to melatonin-induced 
apoptotic process. Adding to the results that P38 inhibitor 
could also suppress PI3K/Akt and HSP27 activation, these 
findings suggest that P38, through its regulation of PI3K/
Akt/HSP27 anti-apoptosis pathway, serves as a suppressor 
of melatonin-stimulated SGC-7901 cells apoptosis.
Intriguingly, in contrast to the well-established pro-
apoptotic roles of melatonin, our study revealed clearly 
a distinguishable anti-apoptotic pathway induced by 
melatonin. Taken together, all these results demonstrate 
that HSP27 plays a crucial role in apoptotic resistance in 
melatonin-treated SGC-7901 gastric cancer cells, and its 
activation is most likely via the activation of P38/PI3K/
Akt signaling by melatonin. These findings are of poten-
tial pathophysiological importance for understanding the 
integration of melatonin-related signaling and further 
substantiate the molecular basis for clinical trials apply-
ing melatonin for the treatment of gastric cancer.
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